Home/Pipeline/Orion pain portfolio candidates

Orion pain portfolio candidates

Chronic pain

Not Specified / VariousActive

Key Facts

Indication

Chronic pain

Phase

Not Specified / Various

Status

Active

Company

Orion

About Orion

Orion Corporation is a well-established, publicly traded Finnish pharmaceutical company with a diversified business spanning human prescription medicines, self-care products, veterinary medicines, and active pharmaceutical ingredient manufacturing. Founded over 100 years ago, it has a strong commercial footprint, particularly in Europe, and a late-stage R&D pipeline concentrated in oncology and pain. The company's strategy balances internal R&D with external partnerships and leverages its integrated API manufacturing capabilities for competitive advantage.

View full company profile

Therapeutic Areas

Oncology Pain Neurological diseases Respiratory diseases Women's health

Other Chronic pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active